Drug Information for Diabetes Mellitus Outpatients at RSUD X Surabaya: What was Provided and what was Known?

  • Shieny Agustin Santoso Faculty of Pharmacy, University of Surabaya, Surabaya, East Java, 60293, Indonesia
  • Adji Prayitno Setiadi Center for Medicines Information and Pharmaceutical Care (CMIPC), Faculty of Pharmacy, University of Surabaya, Surabaya, East Java, 60293, Indonesia
  • Karina Kumaladewi Widjaja Center for Medicines Information and Pharmaceutical Care (CMIPC), Faculty of Pharmacy, University of Surabaya, Surabaya, East Java, 60293, Indonesia
  • Yosi Irawati Wibowo Center for Medicines Information and Pharmaceutical Care (CMIPC), Faculty of Pharmacy, University of Surabaya, Surabaya, East Java, 60293, Indonesia
DOI: https://doi.org/10.35814/jifi.v21i1.1104

Abstract

The prevalence of Diabetes Mellitus (DM) in Indonesia has increased 0.5% in the last five years. This study aimed to evaluate information provided and level of knowledge among DM patients on their treatment at the outpatient clinic at the X Public Hospital (Rumah Sakit Umum Daerah, RSUD), Surabaya, Indonesia. This was a cross-sectional study using a checklist developed by The Food And Drug Supervisory Agency which consists of 11 types of information. The data were analysed descriptively; to test the relationship between the amount of information provided and the patient's level of knowledge, Spearman correlation analysis was used. A total of 110 patients were included in this study (response rate 90.91%). The mean of information provided and understood by patients was 6.48/11±0.73 and 7.48/11±0.90, respectively. There was a significant relationship between information provided to and known by patients (p=0.001). Characteristic factors such as age (p=0.001), education level (p=0.001), and sources of information related to DM (p=0.014) were shown to influence DM patients' knowledge of their treatment. This study indicated the importance of providing clear and complete drug information, especially for patients on long-term therapy, to improve their knowledge, thus potentially increasing adherence and optimizing therapy outcomes.

References

1. American Diabetes Association. Standards of Medical Care in Diabetes. American Diabetes Association Inc. 2020;43(1):1–212.

2. World Health Association. Diabetes Fact Sheet [Internet]. WHO. 2016. [cited 15 November 2017]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0010/305389/Diabetes-Fact-Sheet-en.pdf

3. International Diabetes Federation. IDF Diabetes Atlas Edisi ke-7. Belgium: International Diabetes Federation Inc; 2015.

4. Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (RISKESDAS) 2013. Lap. Nas. 2013;1–384.

5. Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (RISKESDAS) 2018. Lap. Nas. 2018;1–674.

6. Edwina DA, Manaf A, Efrida. Pola Komplikasi Kronis Penderita Diabetes Melitus Tipe 2 Rawat Inap di Bagian Penyakit Dalam RS Dr. M. Djamil Padang Januari 2011-Desember 2012. Jurnal Kesehatan Andalas. 2015;4(1):102-106. https://doi.org/10.25077/jka.v4i1.207

7. Haryono R, Effendy C, Aulawi K. Gambaran Pelaksanaan Discharge Planning Pada Pasien Diabetes Mellitus
[Internet]. JIK. 2008 [cited 29 January 2021]. Available from: https://jurnal.ugm.ac.id/jik/article/view/10294/7777

8. Notoatmodjo S. Promosi Kesehatan dan Ilmu Perilaku. Jakarta: PT Rineka Cipta; 2007.

9. Sari EM. Pengaruh Pemberian Informasi Obat Antihipertensi Terhadap Tingkat Pengetahuan Pasien Tentang
Obat Antihipertensi [Internet]. Akademi Farmasi Putra Malang. 2018 [cited 30 December 2020]. Available from: http://repository.pimedu.ac.id/id/eprint/332/1/ARTIKEL%20ILMIAH%20ELLA%20MONICA_15039.pdf

10. Kerzman H, Baron-Epel, Toren. What do Discharge Patient Know About Their Medication? Patient Education and Counseling. Philadhelpia. 2005;56(3):276-282. https://doi.org/10.1016/j.pec.2004.02.019

11. Azwar A, Joedo P. Metodologi Penelitian Kedokteran dan Kesehatan Masyarakat. Jakarta: Binapura Aksara; 2014.

12. Badan Pengawas Obat dan Makanan. Kriteria dan Tatalaksana Registrasi Obat. BPOM. 2017:1-259.

13. Cohen J. A Coefficient of Aggrement for Nominal Scales. Educ Psychol Meas. 1960;20:37-46. https://doi.org/10.1177/001316446002000104

14. Rantucci MJ. Komunikasi Apoteker-Pasien: Panduan Konseling Pasien Edisi ke-2. Jakarta: Buku Kedokteran EGC; 2007.

15. Gaurav T, Ruchi T, Birendra S. Drug Delivery Systems: An Updated Review. Int J Pharm Investig. 2012;2(1):2-11. https://doi.org/10.4103/2230-973X.96920

16. Kementrian Kesehatan RI. Modul Penggunaan Obat Rasional. Jakarta; 2011.

17. Departemen Kesehatan RI. Pharmaceutical Care Untuk Penyakit Diabetes Mellitus. Jakarta; 2005.

18. Hayati N. Cara Menyimpan Obat dan Jangka Waktu Penyimpanan Obat. Jakarta: Informasi Perlindungan Kesehatan; 2016.

19. Hartayu TS, Widayati A, Wijoyo Y. Peningkatan Pelayanan Informasi Obat bagi Pasien Diabetes Melitus. Jurnal Farmasi Klinik Indonesia. 2013;2(3):102-111. https://doi.org/10.15416/ijcp

20. Suryandari L. Analisis Kualitas Informasi Obat Untuk Pasien di Apotek Kota Surakarta [Skripsi]. Surakarta: Universitas Muhammadiyah; 2015.

21. Ganong WF. Fisiologi Kedokteran Edisi ke-22. Jakarta: EGC; 2008.

22. Gultom YT. Tingkat Pengetahuan Pasien Diabetes Mellitus Tentang Manajemen Diabetes Mellitus di Rumah Sakit Pusat Angkatan Darat Gatot Soebroto Jakarta Pusat [Undergraduate Thesis]. Jakarta: Universitas Indonesia; 2012.

23. Octaviani P. Pengaruh Pemberian Konseling Farmasis dengan Alat Bantu Terhadap Kepatuhan Pasien Diabetes Melitus Tipe 2 Anggota Prolanis di Puskesmas Purwokerto Utara. Viva Medika. 2017;10(1):68-78. https://doi.org/10.35960/VM.V10I2.370

24. Srikartika VM, Akbar MR, Lingga HN. Evaluasi Intervensi Media Booklet Terhadap Tingkat Pengetahuan dan
Kepatuhan Pasien Diabetes Melitus Tipe 2 di Puskesmas Banjarbaru Selatan. Jurnal Publikasi Kesehatan Masyarakat Indonesia. 2019;6(1):27-35. https://doi.org/10.20527/jpkmi.v6i1.6874

25. Dini A. Gambaran Pengetahuan Penderita Tuberkulosis Paru Tentang Penyakit dan Pengobatan Tuberkulosis di RSUP Adam Malik Medan [Undergraduate Thesis]. Medan: Universitas Sumatera Utara; 2010.

26. Irawan E. Faktor-Faktor Yang Berhubungan Dengan Pengetahuan Masyarakat Tentang Diabetes Mellitus Tipe 2 [Internet]. Jurnal Keperawatan BSI. 2018 [cited 29 January 2021]. Available from: https://ejournal.bsi.ac.id/ejurnal/index.php/jk/article/view/4316

27. Notoatmodjo S. Promosi Kesehatan. Jakarta: Salemba Medika; 2010.

28. Nurcahya D. Hubungan Pengetahuan Mengenai Diabetes Melitus Dengan Kualitas Hidup Penderita Diabetes Melitus Tipe 2 di RSUP Haji Adam Malik Medan [Undergraduate Thesis]. Medan: Universitas Sumatera Utara; 2017.
Published
2023-04-28
How to Cite
SANTOSO, Shieny Agustin et al. Drug Information for Diabetes Mellitus Outpatients at RSUD X Surabaya: What was Provided and what was Known?. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 21, n. 1, p. 27-33, apr. 2023. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/1104>. Date accessed: 27 july 2024. doi: https://doi.org/10.35814/jifi.v21i1.1104.
Citation Formats
Issue
Vol 21 No 1 (2023): JIFI
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.